S1 Biopharma, Inc.

FDA has heeded a recommendation by scientific experts and agreed that “associated distress” may be a co-primary endpoint for clinical trials of drugs intended to treat low sexual interest, desire, and

IN VITRO DIAGNOSTICS Alliances AEterna Zentaris Inc. Armune BioScience Inc. Armune BioScience Inc. granted AEterna Zentaris Inc. rights to sell its Apifiny prostate cancer diagnostic to desi

SEOUL - Chong Kun Dang Pharmaceutical Corp. (CKD) has inked three licensing in agreements with foreign pharma companies this month to commercialize and market their products, in a deal that will b

Sponsors are encouraged about prospects for FDA approval of the first drugs for female sexual desire disorders following a pair of meetings with patients and clinician experts, despite a backlash agai